Ezetimibe And Simvastatin Tablet
Product Images NDC 43598-745

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ezetimibe And Simvastatin (NDC 43598-745). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr.reddys Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container5

Label for Ezetimibe and Simvastatin Tablets 10 mg/10 mg. The label includes strength, NDC 43598-742-90, quantity of 90 tablets, and indicates the product is Rx only. It notes storage conditions and manufacturer as Dr. Reddy's Laboratories LA LLC and distributor as Dr. Reddy's Laboratories Inc. There is a barcode and the label is primarily white with blue and orange text elements.*

FDA Label Image

Container6

Ezetimibe and Simvastatin Tablets 10 mg/20 mg oral tablets packaging label. The label shows the product strength, quantity of 90 tablets, and is labeled for prescription use only. It includes storage instructions and manufacturer information for Dr. Reddy's Laboratories Inc.*

FDA Label Image

Container7

Label for Ezetimibe and Simvastatin Tablets 10 mg/40 mg by Dr. Reddy's Laboratories Inc. The label states the product contains 90 tablets and is for prescription use only. It includes storage instructions, manufacturer and distributor details, dosage guidance reference, and a barcode on the right side.*

FDA Label Image

Container8

Label for Ezetimibe and Simvastatin Tablets 10 mg/80 mg from Dr. Reddy's Laboratories Inc. The label states the product contains 90 tablets and includes storage instructions, dosage note, and manufacturer details. A barcode is present on the right side.*

FDA Label Image

Ezetimibe Structural Formula (Image 01)

Chemical structure diagram of Ezetimibe and Simvastatin, showing the molecular layout with rings, functional groups such as hydroxyl (OH), sulfur (S), oxygen (O), nitrogen (N), and fluorine (F) atoms distinctly represented.*

FDA Label Image

Simvastatin Structural Formula (Image 02)

Chemical structure of Ezetimibe and Simvastatin, showing molecular bonds and stereochemistry typical for this combination drug used in cholesterol management.*

FDA Label Image

Figure 1: Effect Of Ezetimibe And Simvastatin On The Primary Endpoint Of Risk Of Major Vascular Events (Image 03)

A line graph depicting major vascular events over a 5-year follow-up period, comparing patients on placebo versus Ezetimibe and Simvastatin. The y-axis shows the percentage of patients with events, and the x-axis shows years of follow-up. The graph includes patient counts at risk for each group at yearly intervals. The Ezetimibe and Simvastatin group shows a lower event rate than placebo, with a reported log-rank P value of 0.001 indicating statistical significance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.